Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 4,763 | 4,366 | 3,150 | 1,703 | 0 |
| Gross Profit | 4,763 | 4,366 | 3,150 | 1,703 | N/A |
| Operating Expenses | 14,383 | 5,306 | 4,473 | 11,011 | 0 |
| Operating Income | -9,619 | -940 | -1,323 | -9,308 | N/A |
| Other Income | 101 | 22 | -74 | -3 | 0 |
| Pre-tax Income | -9,518 | -918 | -1,397 | -9,311 | 0 |
| Income Tax | 18 | N/A | N/A | 33 | N/A |
| Net Income Continuous | -9,536 | -918 | -1,397 | -9,344 | N/A |
| Net Income | $-9,536 | $-918 | $-1,397 | $-9,344 | $N/A |
| EPS Basic Total Ops | -2.58 | -0.32 | -0.52 | -3.68 | N/A |
| EPS Basic Continuous Ops | -2.58 | -0.32 | -0.52 | -3.68 | N/A |
| EPS Diluted Total Ops | -2.58 | -0.32 | -0.52 | -3.68 | N/A |
| EPS Diluted Continuous Ops | -2.58 | -0.32 | -0.52 | -3.68 | N/A |
| EBITDA(a) | $-9,619 | $-940 | $-1,322 | $-9,307 | $N/A |